Company: VCYT
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001384101-25-000110
Chunk: 100

Company: VERACYTE, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 100
---
 administrative expenses.

General and administrative

Comparison of the three and six months ended June 30, 2025 and 2024 is as follows (in thousands of dollars, except percentages):

 Three Months Ended June 30,Six Months Ended June 30, 20252024Change%20252024Change%General and administrative expense:        Compensation expense$21,260 $23,107 $(1,847)(8)%$41,433 $40,866 $567 1 %Professional fees11,995 6,616 5,379 81 %26,716 14,080 12,636 90 %Information technology expense3,636 3,089 547 18 %7,225 5,830 1,395 24 %Occupancy costs2,807 2,539 268 11 %5,918 5,092 826 16 %Depreciation and amortization960 999 (39)(4)%2,016 1,965 51 3 %Revaluation of acquisition-related contingent consideration(925)857 (1,782)(208)%(2,879)863 (3,742)(434)%Other expenses1,261 1,344 (83)(6)%2,628 2,651 (23)(1)%Allocations(8,663)(6,806)(1,857)27 %(16,918)(13,392)(3,526)26 %Total$32,331 $31,745 $586 2 %$66,139 $57,955 $8,184 14 %

General and administrative expense increased by $0.6 million for the three months ended June 30, 2025, compared to the same period in 2024. The results were impacted primarily by an increase of $4.2 million in professional fees mainly related to the Veracyte SAS collective proceedings petition filing, as well as information technology expense increases related to our cloud infrastructure and software development investments. These increases were offset by reductions in the revaluation of contingent consideration related to the acquisitions of C2i and nCounter diagnostic rights, and compensation expense given the prior year expense related to the voluntary Veracyte SAS employee exits. General and administrative expenses related to occupancy costs and information technology costs are allocated to general and administrative expense, selling and marketing expense, research and development